FIGO recognises the urgent need for safe and effective preventive measures against epithelial ovarian cancer—one of the most ...

This year’s theme focuses on Menopause and Menopause Hormone Therapy (MHT), also known as Hormone Replacement Therapy (HRT), ...

We are delighted to celebrate that the EngenderHealth-led consortium FIGO is part of has been awarded a $89 million USAID ...

As FIGO president from 1991 to 1994 and editor of the International Journal of Gynecology and Obstetrics (IJGO) from 1985 to ...

The International Journal of Gynecology & Obstetrics (IJGO) has published the compelling new editorial ‘Beyond borders: The ...

Limited access to high quality prenatal care, skilled birth attendants and emergency obstetric services substantially contributes to elevated rates of maternal deaths and disease, as well as adverse ...

In early 2020, FIGO began to develop a series of free webinars, with the aim of bringing together the global community of women's health experts, advocates, early-career and frontline health ...

May 2019, FIGO released Guidelines to combat pre-eclampsia, and calls for all women to receive first-trimester screening. Read the Pre-eclampsia Guidelines here. 76,000 women and 500,000 babies die ...

The Committee on Menstrual Disorders and Related Health Impacts focuses on the set of symptoms described as non-gestational abnormal uterine bleeding (AUB), including heavy menstrual bleeding (HMB).

FIGO regularly issues statements and joint statements.

The project ended in India and Sri Lanka in December 2018, Nepal in June 2019, Kenya in September 2019, Tanzania in March 2020 and in Bangladesh in October 2020. Across 48 Referral Hospitals, the ...

FIGO Divisions and Committees bring together experts from our member societies with other health care professionals focusing on specialist areas of obstetrics and gynaecology to encourage global ...